From todays Globes (Google translation):
The company revealed in experiments CF101, which she explores several inflammatory diseases, because the active base is also suitable drug for erectile dysfunction.
"We've seen patients do not return us to the remainders of the experimental drug," says Prof. Pnina Fishman, Can-Fite CEO. "When we were discussing why, we discovered that there were trial patients with sexual dysfunction, and enjoyed the repetition of their ability while taking our medicine, while half an hour of taking the drug. "
- Did you see that the animals?
"It turned out that the members of our laboratory saw the phenomenon, laughed and didn't attribut too much importance."
- How does it work? What is the relationship between anti - inflammatory and impotence?
"Recent studies have shown that the medical material Adenosine, the same stuff that makes our medicine, is associated with relaxation of the blood vessels is part of the process of erection."
scientifically interesting, but no market value. ED is a crowded market. Most people dont realize that just before Qsymia approval, VVUS had another drug approved for ED that is probbaly the best in class and def is quickest to erection, but they cant sell it or themselves.
I believe this will happen even if it takes longer than predicted. How many projects does your employer, or your team (or yourself) ever complete on time? (If you are more efficient than most people and tend to complete your projects on time, I apologize for the insinuation.)
Clarification: even though I have no position, I do keep my fingers crossed for the company.